Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sheng Lv

Showing results (61-70 of 63) with videos related to

Pageof 7
Sort By:
You have reached the last page of results.This site can display upto 63 results.
Drug Design, Development and Therapy|March 29, 2021
Study on the Mechanism of Jiawei Shengjiang Powder in Improving Male Asthma-Induced Asthenospermia Based on Network Pharmacology and BioinformaticsJi-Sheng Wang, Xue-Feng Gong, Jun-Long Feng, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|January 11, 2024
Application of improved GalNAc conjugation in development of cost-effective siRNA therapies targeting cardiovascular diseasesQian Li, Ke Yin, Hai-Ping Ma, et al.
International Journal of Antimicrobial Agents|April 1, 2026
Efficacy, Safety, and Population Pharmacokinetics of Eravacycline for Carbapenem-Resistant Organism Infections in Immunocompromised Hosts: A Multicenter Prospective Cohort StudyYifu Hou, Lijuan Zhang, Hong Li, et al.
Pageof 7

Showing results (61-70 of 63) with videos related to

Sort By:
Pageof 7
You have reached the last page of results.This site can display upto 63 results.
Drug Design, Development and Therapy|March 29, 2021
Study on the Mechanism of Jiawei Shengjiang Powder in Improving Male Asthma-Induced Asthenospermia Based on Network Pharmacology and BioinformaticsJi-Sheng Wang, Xue-Feng Gong, Jun-Long Feng, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|January 11, 2024
Application of improved GalNAc conjugation in development of cost-effective siRNA therapies targeting cardiovascular diseasesQian Li, Ke Yin, Hai-Ping Ma, et al.
International Journal of Antimicrobial Agents|April 1, 2026
Efficacy, Safety, and Population Pharmacokinetics of Eravacycline for Carbapenem-Resistant Organism Infections in Immunocompromised Hosts: A Multicenter Prospective Cohort StudyYifu Hou, Lijuan Zhang, Hong Li, et al.
Pageof 7